Effect of aminophylline on plasma [K+] and hypoxic ventilatory response during mild exercise in men.
To examine the role of endogenous adenosine on the hypoxic ventilatory response (HVR) enhanced during exercise, we measured HVR at rest and during mild exercise (12.5 W) in nine healthy men in a supine position after pretreatment with aminophylline (5 mg/kg), an adenosine receptor blocker, or dipyridamole (0.6 mg/kg), an adenosine uptake blocker, by using a 3-day double-blind placebo-controlled design. Although HVR was enhanced during exercise on all occasions, HVR with aminophylline [0.42 +/- 0.07 (SE) l.min-1.%fall-1 of arterial O2 saturation] was significantly lower than that with placebo (0.64 +/- 0.13 l.min-1.%fall-1) or dipyridamole (0.64 +/- 0.08 l.min-1.%fall-1) during exercise (P < 0.05 for both) at similar end-tidal PCO2 on the 3 days but not at rest. We then examined the changes in plasma K+ concentration ([K+]) and catecholamines, the other possible endogenous potentiators of the carotid body activity. The exercise- and hypoxia-induced increases in plasma [K+] were significantly lower with aminophylline (0.23 +/- 0.09 meq/l) than with the placebo (0.51 +/- 0.10 meq/l) or dypyridamole (0.58 +/- 0.13 meq/l) (P < 0.05 for both). We therefore conclude that aminophylline attenuates the enhancement of HVR during mild exercise and that this might be due to its attenuating effect on exercise- and hypoxia-associated increases in plasma [K+] rather than due to its antagonizing effect on endogenous adenosine.
Igarashi
T
T
First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Nishimura
M
M
Akiyama
Y
Y
Yamamoto
M
M
Miyamoto
K
K
Kawakami
Y
Y
D000293:Adolescent; D000328:Adult; D000628:Aminophylline / Q000494:pharmacology*; D002395:Catecholamines / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D004176:Dipyridamole / Q000494:pharmacology; D004311:Double-Blind Method; D015444:Exercise / Q000502:physiology*; D016231:Fluorescence Polarization Immunoassay; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D007262:Infusions, Intravenous; D008297:Male; D011188:Potassium / Q000097:blood*; D012119:Respiration / Q000187:drug effects* / Q000502:physiology
D002395:Catecholamines; D000628:Aminophylline; D004176:Dipyridamole; D011188:Potassium